Medical supply distributor PSS World Medical reported last month that its subsidiary, Diagnostic Imaging, has purchased four more companies. Jacksonville, FL-based Diagnostic Imaging acquired two California firms, Intra-Trade Medical, a provider of
Medical supply distributor PSS World Medical reported last month that its subsidiary, Diagnostic Imaging, has purchased four more companies. Jacksonville, FL-based Diagnostic Imaging acquired two California firms, Intra-Trade Medical, a provider of consumable imaging products, and QA Processor Service, a film-handling service company. It also bought Vanguard Imaging, a cardiovascular catheterization lab service provider in New York, as well as Palm Beach X-Ray, an imaging distributor in Florida. Diagnostic Imaging expects its purchases to bolster its annual revenues by roughly $45 million. PSS World has acquired at least eight distributors since the beginning of the year, adding to its existing network of more than 61 sites across the U.S.
In other PSSWorld news, the company this month signed an exclusive distributorship agreement with Siemens Medical Systems. Under the terms of the deal, PSSWorld will supply Siemens ultrasound systems to physicians in its distributor network.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.